Document Classification

Section Type: RESULTS

Text: From the results, it is obvious that throughout the cross-over periods the nabilone treatment was superior (medians [25 % - ; 75 % - percentiles] : nabilone/placebo) : decrease of the average spinal pain intensity within the last 4 weeks (DeltaVAS) 0. 9 [0. 0 ; 2. 0] / 0. 5 [0. 0 ; 1. 7], decrease of the current spinal pain intensity (DeltaVAS) 0. 6 [0. 0 ; 2. 5] / 0. 0 [-1. 0, 1. 0] (p =. 006), decrease of the average headache intensity within the last 4 weeks (DeltaVAS) 1. 0 [-1. 0 ; 2. 4] / 0. 2 [-0. 9 ; 1. 0], increase of the number of days without headache within the last 4 weeks 2. 0 [0. 0 ; 6. 5] / 0. 0 [-5. 0 ; 4. 0], increase of the quality of life (DeltaQOL-Score) 5. 0 [0. 8 ; 10. 8] / 2. 0 [-2. 3 ; 8. 0].